Casdin Eli's Form 4 filing
Standard Biotools Inc. (LAB) · filed May 19, 2023
- Accession no.
- 0000919574-23-003426
- Filed
- May 19, 2023
- Trade date
- May 17-19, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.63M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casdin EliCIK 0001534264 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2023 | Common Stock | PPurchaseAcquired | +250,000 | $1.89 | +$472,500 | 250,000 | Indirect | |
| May 18, 2023 | Common Stock | PPurchaseAcquired | +150,000 | $2.16 | +$324,000 | 400,000 | Indirect | |
| May 19, 2023 | Common Stock | PPurchaseAcquired | +800,000 | $2.29 | +$1,832,000 | 1,200,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.